What We Know and What We Do Not Know About Factors Associated with and Interventions to Promote Antiretroviral Adherence

被引:14
作者
Mannheimer, Sharon [1 ,2 ]
Hirsch-Moverman, Yael [3 ]
机构
[1] Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA
[2] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10037 USA
[3] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY 10027 USA
关键词
Adherence; HIV; Antiretroviral therapy; Intervention; Predictors; MEDICATION ADHERENCE; UNITED-STATES; VIRAL SUPPRESSION; SUSTAINED BENEFIT; IMPROVE ADHERENCE; HIV TRANSMISSION; CONTROLLED-TRIAL; HAART-ADHERENCE; DRUG-USERS; CELL COUNT;
D O I
10.1007/s11908-015-0466-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antiretroviral therapy (ART) adherence remains critical for achieving successful outcomes. Factors affecting ART adherence can occur at the individual level or be related to the treatment regimen, daily schedule, and/or interpersonal relationships. While treatment-related barriers have diminished with recent simplified ART regimens, guidelines still recommend considering regimen simplicity. ART readiness should be assessed prior to starting ART, with follow-up adherence assessments once ART is initiated, and at all subsequent clinical visits. Adherence interventions work best when multifaceted, targeted for at-risk and nonadherent participants, and tailored to individuals' needs. Successful interventions have included education and counseling, provision of social support, directly observed therapy, and financial incentives. Pillboxes and two-way short-text messaging service (SMS) reminders have been shown to be effective and are widely recommended tools for promoting ART adherence. Further research is needed to determine the optimal combination of adherence interventions, as well as generalizability, implementation, and cost-effectiveness.
引用
收藏
页数:8
相关论文
共 84 条
[1]  
Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008
[2]  
Amico K Rivet, 2013, J Int Assoc Provid AIDS Care, V12, P128, DOI 10.1177/1545109712459041
[3]  
[Anonymous], 2007, NATL SURVEY INFECT D
[4]  
[Anonymous], AIDS BEHAV
[5]   An Evidence-Based Review of Treatment-Related Determinants of Patients' Nonadherence to HIV Medications [J].
Atkinson, Mark J. ;
Petrozzino, Jeffrey J. .
AIDS PATIENT CARE AND STDS, 2009, 23 (11) :903-914
[6]   Accessing Antiretroviral Therapy Following Release From Prison [J].
Baillargeon, Jacques ;
Giordano, Thomas P. ;
Rich, Josiah D. ;
Wu, Z. Helen ;
Wells, Katherine ;
Pollock, Brad H. ;
Paar, David P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (08) :848-857
[7]   A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV plus homeless and marginally housed people [J].
Bangsberg, David R. ;
Ragland, Kathleen ;
Monk, Alex ;
Deeks, Steven G. .
AIDS, 2010, 24 (18) :2835-2840
[8]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[9]   Disparities in HIV transmission risk among HIV-infected black and white men who have sex with men, United States, 2009 [J].
Beer, Linda ;
Oster, Alexandra M. ;
Mattson, Christine L. ;
Skarbinski, Jacek .
AIDS, 2014, 28 (01) :105-114
[10]   Lack of Sustained Improvement in Adherence or Viral Load Following a Directly Observed Antiretroviral Therapy Intervention [J].
Berg, Karina M. ;
Litwin, Alain H. ;
Li, Xuan ;
Heo, Moonseong ;
Arnsten, Julia H. .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (09) :936-943